CD274 and melanoma: Moreover, in a retrospective analysis of 44 patients affected by metastatic tumors (including 29 melanoma patients) and concurrent solid organ transplant, HIV, HBV or HCV infections, the administration of anti-PD-1/PD-L1 mAbs appeared to have clinical activity in the absence of adverse effect on the viral control [61].